News
By embracing a mix of co-innovation and best practices, stakeholders can boost productivity, streamline clinical trials, and ...
C linical research is an essential piece of medical innovation— and yet it is inaccessible to far too many people. For too long, clinical ... Alongside industry stakeholders, the organization ...
In this video interview, Rob Jones, product manager, TMF practice area, Pharmalex, shares his key takeaways from Cencora’s ...
As the industry prioritises health equity and inclusion in clinical research ... get-go will be the key to opening the treasure box of tangible benefits of DCTs for all stakeholders.
When thinking of clinical research, small businesses are rarely the first thing that comes to mind. Yet, despite the obvious ...
One of the key themes of the WHO guidance is ensuring ... The paper discusses the need for harmonisation between stakeholders in clinical trials to try and improve accessibility to research ...
1mon
GlobalData on MSNInvestigating key strategies for optimising clinical trial supply chains in 2025A key session on day one will delve into ... a critical aspect of managing complex clinical trials. As stakeholders demand ...
Clinical academia is on a steep decline globally. In the UK, a 6% reduction in the number of clinical academics since 2012 has been reported, with the number of senior lecturer level researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results